Cargando…

Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction

Interleukin (IL)-6 is an emerging therapeutic target in myocardial infarction (MI). IL-6 has 2 distinct signaling pathways: trans-signaling, which mediates inflammation, and classic signaling, which also has anti-inflammatory effects. The novel recombinant fusion protein sgp130Fc achieves exclusive...

Descripción completa

Detalles Bibliográficos
Autores principales:	George, Marc Jonathan, Jasmin, Nur Hayati, Cummings, Valerie Taylor, Richard-Loendt, Angela, Launchbury, Francesca, Woollard, Kevin, Turner-Stokes, Tabitha, Garcia Diaz, Ana Isabel, Lythgoe, Mark, Stuckey, Daniel James, Hingorani, Aroon Dinesh, Gilroy, Derek William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Preclinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165121/ https://www.ncbi.nlm.nih.gov/pubmed/34095633 http://dx.doi.org/10.1016/j.jacbts.2021.01.013

Ejemplares similares

Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition
por: Francisco, Jamie, et al.
Publicado: (2020)

Targeting IL-6 Trans-Signaling: Amplifying the Benefits of IL-6 Inhibition in Myocardial Infarction
por: Aukrust, Pål, et al.
Publicado: (2021)

Prostacyclin Analogue–Loaded Nanoparticles Attenuate Myocardial Ischemia/Reperfusion Injury in Rats
por: Yajima, Shin, et al.
Publicado: (2019)

Aberrant insular cortex connectivity in abstinent alcohol‐dependent rats is reversed by dopamine D3 receptor blockade
por: Scuppa, Giulia, et al.
Publicado: (2019)

Clec4e-Receptor Signaling in Myocardial Repair After Ischemia-Reperfusion Injury
por: Veltman, Denise, et al.
Publicado: (2021)

Investigating the role of endogenous estrogens, hormone replacement therapy, and blockade of estrogen receptor-α activity on breast metabolic signaling
por: Arnone, Alana A., et al.
Publicado: (2021)

Cathepsin A Mediates Ventricular Remote Remodeling and Atrial Cardiomyopathy in Rats With Ventricular Ischemia/Reperfusion
por: Hohl, Mathias, et al.
Publicado: (2019)

Efficacy of a Novel Mitochondrial-Derived Peptide in a Porcine Model of Myocardial Ischemia/Reperfusion Injury
por: Sharp, Thomas E., et al.
Publicado: (2020)

A Sarcoplasmic Reticulum Localized Protein Phosphatase Regulates Phospholamban Phosphorylation and Promotes Ischemia Reperfusion Injury in the Heart
por: Akaike, Toru, et al.
Publicado: (2017)

Diabetes Exacerbates Myocardial Ischemia/Reperfusion Injury by Down-Regulation of MicroRNA and Up-Regulation of O-GlcNAcylation
por: Wang, Dandan, et al.
Publicado: (2018)

Blockade of Myd88 signaling by a novel MyD88 inhibitor prevents colitis-associated colorectal cancer development by impairing myeloid-derived suppressor cells
por: Wang, Lu, et al.
Publicado: (2022)

Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome
por: Xu, Na, et al.
Publicado: (2022)

Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury
por: Miyamoto, Hiroko Deguchi, et al.
Publicado: (2022)

Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A
por: Nordlohne, Johannes, et al.
Publicado: (2018)

Associations of Interleukin-5 With Plaque Development and Cardiovascular Events
por: Knutsson, Anki, et al.
Publicado: (2019)

Novel GSK-3β Inhibitor Neopetroside A Protects Against Murine Myocardial Ischemia/Reperfusion Injury
por: Kim, Hyoung Kyu, et al.
Publicado: (2022)

Inhibition of Interleukin-17A, But Not Interleukin-17F, Signaling Lowers Blood Pressure, and Reduces End-Organ Inflammation in Angiotensin II–Induced Hypertension
por: Saleh, Mohamed A., et al.
Publicado: (2016)

Interleukin-1β, Oxidative Stress, and Abnormal Calcium Handling Mediate Diabetic Arrhythmic Risk
por: Liu, Hong, et al.
Publicado: (2021)

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program
por: Bilous, Michael, et al.
Publicado: (2012)

LncRNA-ZFAS1 Promotes Myocardial Ischemia-Reperfusion Injury Through DNA Methylation-Mediated Notch1 Down-Regulation in Mice
por: Li, Mengmeng, et al.
Publicado: (2022)

N-Farnesyloxy-norcantharimide inhibits progression of human leukemic Jurkat T cells through regulation of mitogen-activated protein kinase and interleukin-2 production
por: Chang, Ming-Che, et al.
Publicado: (2015)

Myocardial Viability Imaging using Manganese‐Enhanced MRI in the First Hours after Myocardial Infarction
por: Jasmin, Nur Hayati, et al.
Publicado: (2021)

Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study
por: Shah, Anoop Dinesh, et al.
Publicado: (2016)

Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study
por: Shah, Anoop Dinesh, et al.
Publicado: (2017)

Central carbon metabolism in the progression of mammary carcinoma
por: Richardson, Adam D., et al.
Publicado: (2007)

The spectrum of ATM missense variants and their contribution to contralateral breast cancer
por: Broeks, Annegien, et al.
Publicado: (2007)

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
por: Rajput, Ashish B., et al.
Publicado: (2007)

Loss of expression of FANCD2 protein in sporadic and hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2007)

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
por: Ma, Brigette B.Y., et al.
Publicado: (2009)

Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice
por: Oostendorp, Roos L., et al.
Publicado: (2010)

Pankiller effect of prolonged exposure to menadione on glioma cells: potentiation by vitamin C
por: Vita, Marina F., et al.
Publicado: (2010)

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance
por: Buyse, Gunnar M., et al.
Publicado: (2009)

Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
por: O’Donnell, Robert T., et al.
Publicado: (2009)

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles
por: Goette, Andreas, et al.
Publicado: (2009)

CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo
por: Koch, Manuel, et al.
Publicado: (2010)

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
por: Harrell, J. Chuck, et al.
Publicado: (2011)

Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression
por: Skibicka, Karolina P, et al.
Publicado: (2012)

Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2
por: Goyeneche, Alicia A., et al.
Publicado: (2011)

Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system
por: Jerlhag, Elisabet, et al.
Publicado: (2011)

Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models
por: Bergman, Andries M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p51vknthlqdjkpmnd4qnpvso2a